Que, Wan-Cai <br/><br/>
Paclitaxel, 5-fluorouracil, and leucovorin combination chemotherapy as first-line treatment in patients with advanced gastric cancer.  [electronic resource] 

 -  Anti-cancer drugs  03 2019 
 - 302-307 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-5741 
<br/><br/><label>Standard No.: </label>10.1097/CAD.0000000000000735  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Female<br/>Fluorouracil--administration & dosage<br/>Follow-Up Studies<br/>Humans<br/>Leucovorin--administration & dosage<br/>Lymphatic Metastasis<br/>Male<br/>Middle Aged<br/>Paclitaxel--administration & dosage<br/>Prognosis<br/>Retrospective Studies<br/>Stomach Neoplasms--drug therapy<br/>Survival Rate<br/>Young Adult